VIVEVE MEDICAL, INC. (33)
Browse by Contract Category
Contracts
-
Fifth Amended and Restated Viveve Medical, Inc. Independent Director Compensation Policy
(Filed With SEC on May 12, 2022)
-
Description of Securities
(Filed With SEC on March 17, 2022)
-
First Amendment to Purchase Agreement, dated March 31, 2021, by and between Viveve Medical, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on March 31, 2021)
-
Amendment No. 1 to Sublease Agreement, effective as of March 15, 2021, by and between the Registrant and Ingredion Incorporated
(Filed With SEC on March 18, 2021)
-
Sales Agreement, dated August 16, 2019, by and among Viveve Medical, Inc. and Ladenburg Thalmann & Co. Inc
(Filed With SEC on August 16, 2019)
-
Form of Retention Bonus Agreement
(Filed With SEC on January 21, 2022)
-
Description of Securities
(Filed With SEC on March 18, 2021)
-
Form of Warrant Agent Agreement by and between VStock Transfer LLC and the Registrant, effective January 2021
(Filed With SEC on January 12, 2021)
-
Form of Common Stock Purchase Warrant for the 2021 Warrants
(Filed With SEC on January 12, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on January 12, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on December 31, 2020)
-
Registration Rights Agreement, dated June 8, 2020, by and between Viveve Medical, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on June 10, 2020)
-
Purchase Agreement, dated June 8, 2020, by and between Viveve Medical, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on June 10, 2020)
-
Promissory Note, dated April 24, 2020, by and between Viveve and the Lender
(Filed With SEC on April 24, 2020)
-
Form of Inducement Letter
(Filed With SEC on April 17, 2020)
-
Form of Series A-2/B-2 Common Stock Purchase Warrant
(Filed With SEC on April 17, 2020)
-
Description of Securities
(Filed With SEC on March 19, 2020)
-
Form of Warrant for the Offering
(Filed With SEC on November 21, 2019)
-
Amendment No. 1 to the Series B Preferred Stock and Warrant Purchase Agreement, dated as of November 20, 2019, by and between the Registrant and CRG
(Filed With SEC on November 21, 2019)
-
Form of Warrant for CRG
(Filed With SEC on November 21, 2019)
-
Form of Warrant Agent Agreement between Viveve Medical, Inc. and VStock Transfer, LLC
(Filed With SEC on November 21, 2019)
-
Form of Warrant for the Offering
(Filed With SEC on November 21, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on November 21, 2019)
-
Lock-Up Agreement between CRG and and Ladenburg Thalmann & Co. Inc., dated as of November 12, 2019
(Filed With SEC on November 13, 2019)
-
Series B Preferred Stock and Warrant Purchase Agreement, dated as of November 12, 2019, by and between the Registrant and CRG
(Filed With SEC on November 13, 2019)
-
Amendment No. 3 to the Loan Agreement, dated as of November 12, 2019, by and between the Registrant and CRG
(Filed With SEC on November 13, 2019)
-
Form of Registration Rights Agreement by and between the Registrant and CRG
(Filed With SEC on November 13, 2019)
-
Form of Warrant for CRG
(Filed With SEC on November 13, 2019)
-
Form of Warrant Agent Agreement between Viveve Medical, Inc. and VStock Transfer, LLC
(Filed With SEC on November 13, 2019)
-
Form of Warrant for the Offering
(Filed With SEC on November 13, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on November 13, 2019)
-
Viveve Medical, Inc. 2013 Stock Option and Incentive Plan, as amended
(Filed With SEC on September 18, 2019)
-
Relocation Agreement, by and between Viveve Medical, Inc. and Jim Robbins, dated August 22, 2017
(Filed With SEC on May 9, 2019)
